BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sousa AGP, Cabral JVS, El-Feghaly WB, Sousa LS, Nunes AB. Hyporeninemic hypoaldosteronism and diabetes mellitus: Pathophysiology assumptions, clinical aspects and implications for management. World J Diabetes 2016; 7(5): 101-111 [PMID: 26981183 DOI: 10.4239/wjd.v7.i5.101]
URL: https://www.wjgnet.com/1948-9358/full/v7/i5/101.htm
Number Citing Articles
1
Josep Redon, Fernando Martinez. Blood Pressure Disorders in Diabetes MellitusUpdates in Hypertension and Cardiovascular Protection 2023; : 39 doi: 10.1007/978-3-031-13009-0_3
2
Murat Özdede, Alper Tuna Güven. Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors: commentInternal and Emergency Medicine 2024; 19(3): 879 doi: 10.1007/s11739-023-03520-4
3
Hiroki Yamaguchi, Michihiro Hosojima, Hideyuki Kabasawa, Yumi Ito, Yoshiki Suzuki, Akihiko Saito, Masaaki Arakawa, Ichiei Narita. A case of idiopathic nodular glomerulosclerosis successfully treated by intensive blockade of the renin–angiotensin–aldosterone systemCEN Case Reports 2022; 12(3): 311 doi: 10.1007/s13730-022-00766-3
4
Zubaid Rafique, Maria José Fortuny, Dick Kuo, Lukasz Szarpak, Lluís Llauger, Begoña Espinosa, Víctor Gil, Javier Jacob, Aitor Alquézar-Arbé, Juan Antonio Andueza, José Manuel Garrido, Alfons Aguirre, Marta Fuentes, Héctor Alonso, Francisco Javier Lucas-Imbernón, Carlos Bibiano, Guillermo Burillo-Putze, Julio Núñez, Wilfried Mullens, Pedro Lopez-Ayala, Christian Mueller, Pere Llorens, Frank Peacock, Òscar Miró. Hyperkalemia in acute heart failure: Short term outcomes from the EAHFE registryThe American Journal of Emergency Medicine 2023; 70: 1 doi: 10.1016/j.ajem.2023.05.005
5
John William Honour. Steroids in the Laboratory and Clinical Practice2023; : 935 doi: 10.1016/B978-0-12-818124-9.00021-8
6
Christian A. Koch, Tibor Fulop. Clinical aspects of changes in water and sodium homeostasis in the elderlyReviews in Endocrine and Metabolic Disorders 2017; 18(1): 49 doi: 10.1007/s11154-017-9420-5
7
Eugenia Gkaliagkousi, Panagiota Anyfanti, Antonios Lazaridis, Stella Douma. Plasma renin activity to plasma aldosterone concentration ratio for the assessment of essential hypertensive patients in real-life clinical practiceJournal of Hypertension 2018; 36(2): 444 doi: 10.1097/HJH.0000000000001630
8
Silvia Matino, Francesco Pesce, Michele Rossini, Giuseppina D’Ettorre, Alessandro Mascolo, Loreto Gesualdo. Thyroid DiseasesEndocrinology 2019; : 1 doi: 10.1007/978-3-319-66362-3_5-1
9
Marion Walker, Hari Vivekanantham, Denis Graf. ECG of the month: A “de Winter”-like ECG pattern in a patient presenting with progressive lethargyAnnals of Emergency Medicine 2021; 77(4): 445 doi: 10.1016/j.annemergmed.2020.09.434
10
Jorge Gabriel Ruiz-Sánchez, Alfonso Luis Calle-Pascual, Miguel Ángel Rubio-Herrera, María Paz De Miguel Novoa, Emilia Gómez-Hoyos, Isabelle Runkle. Clinical manifestations and associated factors in acquired hypoaldosteronism in endocrinological practiceFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.990148
11
Bianca Domingues Massolini, Stephanie San Gregorio Contieri, Giulia Severini Lazarini, Paula Antoun Bellacosa, Mirela Dobre, Georg Petroianu, Andrei Brateanu, Luciana Aparecida Campos, Ovidiu Constantin Baltatu. Therapeutic Renin Inhibition in Diabetic Nephropathy—A Review of the Physiological EvidenceFrontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.00190
12
Pasquale Esposito, Novella Evelina Conti, Valeria Falqui, Leda Cipriani, Daniela Picciotto, Francesca Costigliolo, Giacomo Garibotto, Michela Saio, Francesca Viazzi. New Treatment Options for Hyperkalemia in Patients with Chronic Kidney DiseaseJournal of Clinical Medicine 2020; 9(8): 2337 doi: 10.3390/jcm9082337
13
Rehab B. Albakr, Vikas S. Sridhar, David Z.I. Cherney. Novel Therapies in Diabetic Kidney Disease and Risk of Hyperkalemia: A Review of the Evidence From Clinical TrialsAmerican Journal of Kidney Diseases 2023; 82(6): 737 doi: 10.1053/j.ajkd.2023.04.015
14
Kleber Goia-Nishide, Lucas Coregliano-Ring, Érika Bevilaqua Rangel. Hyperkalemia in Diabetes Mellitus SettingDiseases 2022; 10(2): 20 doi: 10.3390/diseases10020020
15
Javier Morales, Biff F. Palmer. Non-steroidal mineralocorticoid antagonists and hyperkalemia monitoring in chronic kidney disease patients associated with type II diabetes: a narrative reviewPostgraduate Medicine 2024; 136(2): 111 doi: 10.1080/00325481.2024.2316572
16
Gadi Shlomai, Anat Berkovitch, Shiran Pinchevski-Kadir, Gil Bornstein, Avshalom Leibowitz, Ilan Goldenberg, Ehud Grossman. The association between normal-range admission potassium levels in Israeli patients with acute coronary syndrome and early and late outcomesMedicine 2016; 95(23): e3778 doi: 10.1097/MD.0000000000003778
17
Masanori Adachi, Sakura Motegi, Keiko Nagahara, Ayako Ochi, Junya Toyoda, Katsumi Mizuno. Classification of pseudohypoaldosteronism type II as type IV renal tubular acidosis: results of a literature reviewEndocrine Journal 2023; 70(7): 723 doi: 10.1507/endocrj.EJ22-0607
18
Practical Diabetes Care2018; : 315 doi: 10.1002/9781119052210.ch11
19
Anna Marco-Ramell, Sara Tulipani, Magali Palau-Rodriguez, Raul Gonzalez-Dominguez, Antonio Miñarro, Olga Jauregui, Alex Sanchez-Pla, Manuel Macias-Gonzalez, Fernando Cardona, Francisco J. Tinahones, Cristina Andres-Lacueva. Untargeted Profiling of Concordant/Discordant Phenotypes of High Insulin Resistance and Obesity To Predict the Risk of Developing DiabetesJournal of Proteome Research 2018; 17(7): 2307 doi: 10.1021/acs.jproteome.7b00855
20
Satoru Kuriyama. A Potential Mechanism of Cardio-Renal Protection with Sodium-Glucose Cotransporter 2 Inhibitors: Amelioration of Renal CongestionKidney and Blood Pressure Research 2019; 44(4): 449 doi: 10.1159/000501081
21
Robert W Hunter, Matthew A Bailey. Hyperkalemia: pathophysiology, risk factors and consequencesNephrology Dialysis Transplantation 2019; 34(Supplement_3): iii2 doi: 10.1093/ndt/gfz206
22
Gladness Dakalo Nethathe, Jeremy Cohen, Jeffrey Lipman, Ronald Anderson, Charles Feldman. Mineralocorticoid Dysfunction during Critical IllnessAnesthesiology 2020; 133(2): 439 doi: 10.1097/ALN.0000000000003365
23
Shrey Purohit, Dalila B. Corry, Michael L. Tuck. Encyclopedia of Endocrine Diseases2018; : 703 doi: 10.1016/B978-0-12-801238-3.95898-7
24
Su‐Min Park, Ju‐Hyun An, Na‐Hyeong Kim, Ye‐In Oh, Kyoung‐won Seo, Hwa‐Young Youn. Isolated hypoaldosteronism managed by DOCP in a dog with chronic kidney disease and hypercortisolismVeterinary Medicine and Science 2022; 8(6): 2292 doi: 10.1002/vms3.954
25
Jodi D. Stookey, Prasanna K.R. Allu, Dorothee Chabas, David Pearce, Florian Lang. Hypotheses about sub-optimal hydration in the weeks before coronavirus disease (COVID-19) as a risk factor for dying from COVID-19Medical Hypotheses 2020; 144: 110237 doi: 10.1016/j.mehy.2020.110237
26
Febriana M Puspita, Em Yunir, Putri S Agustina, Rani Sauriasari. Effect of Angiotensin Receptor Blocker and Angiotensin Converting Enzyme Inhibitor on Kidney Function and Blood Potassium Level in Indonesian Type 2 Diabetes Mellitus with Hypertension: A Three-Month Cohort StudyDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 3841 doi: 10.2147/DMSO.S310091
27
Jennifer E. Clark, Jaime de la Fuente, Luke T. Hafdahl. 66-Year-Old Man With Light-headedness, Chest Pain, and DyspneaMayo Clinic Proceedings 2019; 94(2): e13 doi: 10.1016/j.mayocp.2018.04.030
28
Marco Quaglia, Guido Merlotti, Vincenzo Cantaluppi. Renal tubular acidosisGiornale di Tecniche Nefrologiche e Dialitiche 2016; 28(3): 157 doi: 10.5301/GTND.2016.15989
29
Vincenzo Panuccio, Daniela Leonardis, Rocco Tripepi, Maria Carmela Versace, Claudia Torino, Giovanni Tripepi, Graziella D’Arrigo, Francesca Mallamaci, Carmine Zoccali. Epidemiology of hyperkalemia in CKD patients under nephrological care: a longitudinal studyInternal and Emergency Medicine 2021; 16(7): 1803 doi: 10.1007/s11739-021-02653-8
30
Isao Kurihara. IV. Endocrine Disorders Associated with HyperkalemiaNihon Naika Gakkai Zasshi 2020; 109(4): 727 doi: 10.2169/naika.109.727
31
S. J. H. Dobbin, J. R. Petrie, M. E. J. Lean, G. A. McKay. Fludrocortisone therapy for persistent hyperkalaemiaDiabetic Medicine 2017; 34(7): 1005 doi: 10.1111/dme.13359
32
N.O. Pertseva, T.V. Chursinova, A.A. Gryshniakova. Hyporeninemic hypoaldosteronism as a manifestation of autonomic neuropathy in a patient with type 2 diabetes mellitus against the background of coronavirus disease. A clinical caseINTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2023; 19(2): 149 doi: 10.22141/2224-0721.19.2.2023.1261
33
Alper Tuna Güven, Murat Özdede, Yusuf Ziya Şener, Ali Osman Yıldırım, Sabri Engin Altıntop, Berkay Yeşilyurt, Oğuz Abdullah Uyaroğlu, Mine Durusu Tanrıöver. Evaluation of machine learning algorithms for renin-angiotensin-aldosterone system inhibitors associated renal adverse event predictionEuropean Journal of Internal Medicine 2023; 114: 74 doi: 10.1016/j.ejim.2023.05.021
34
Kohei Okamoto, Hideki Fujii, Kentaro Watanabe, Shunsuke Goto, Keiji Kono, Shinichi Nishi. Changes of FGF23 and the Renin-Angiotensin-System in Male Mouse Models of Chronic Kidney Disease and Cardiac HypertrophyJournal of the Endocrine Society 2022; 6(2) doi: 10.1210/jendso/bvab187
35
Silvio Borrelli, Luca De Nicola, Roberto Minutolo, Giuseppe Conte, Paolo Chiodini, Adamasco Cupisti, Domenico Santoro, Vincenzo Calabrese, Domenico Giannese, Carlo Garofalo, Michele Provenzano, Vincenzo Bellizzi, Luca Apicella, Giorgina Barbara Piccoli, Massimo Torreggiani, Biagio Raffaele Di Iorio. Current Management of Hyperkalemia in Non-Dialysis CKD: Longitudinal Study of Patients Receiving Stable Nephrology CareNutrients 2021; 13(3): 942 doi: 10.3390/nu13030942
36
O. Voloshchuk, I. Lungul, G. Kopylchuk. INDICATORS OF WATER-SALT ВALANCE IN ANIMALS UNDER CONDITIONS OF DIFFERENT NUTRIENT SUPPLYBiolohichni systemy 2021; 13(1) doi: 10.31861/biosystems2021.01.003
37
Chia-Hui Chang, Ya-Hui Hu, Kuo-How Huang, Yen-Hung Lin, Yao-Chou Tsai, Che-Hsiung Wu, Shao-Yu Yang, Chin-Chen Chang, Ching-Chu Lu, Kwan-Dun Wu, Vin-Cent Wu. Higher Screening Aldosterone to Renin Ratio in Primary Aldosteronism Patients with Diabetes MellitusJournal of Clinical Medicine 2018; 7(10): 360 doi: 10.3390/jcm7100360
38
Davide Costa, Gemma Patella, Michele Provenzano, Nicola Ielapi, Teresa Faga, Mariateresa Zicarelli, Franco Arturi, Giuseppe Coppolino, Davide Bolignano, Giovambattista De Sarro, Umberto Marcello Bracale, Luca De Nicola, Paolo Chiodini, Raffaele Serra, Michele Andreucci. Hyperkalemia in CKD: an overview of available therapeutic strategiesFrontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1178140
39
Jamala Mammadova, Cengiz Kara, Eda Çelebi Bitkin, Elif İzci Güllü, Murat Aydın. Nephrogenic Syndrome of Inappropriate Antidiuresis Mimicking Hyporeninemic Hypoaldosteronism: Case Report of Two InfantsJournal of Clinical Research in Pediatric Endocrinology 2023; 15(2): 214 doi: 10.4274/jcrpe.galenos.2021.2021.0191
40
A. V. Semenko, Y. V. Murdasov, S. V. Kirichenko, V. I. Zhyliuk, G. A. Ushakovа. Influence of melatonin on the kidneys of rats with experimental diabetes mellitus type 2Regulatory Mechanisms in Biosystems 2020; 11(3): 384 doi: 10.15421/022059
41
Sara Erraez, Manuel López-Mesa, Pablo Gómez-Fernández. Mineralcorticoid receptor blockers in chronic kidney diseaseNefrología (English Edition) 2021; 41(3): 258 doi: 10.1016/j.nefroe.2021.08.001
42
Masahiro Takubo, Sho Tanaka, Masaru Kushimoto, Jin Ikeda, Katsuhiko Ogawa, Yutaka Suzuki, Masanori Abe, Hisamitsu Ishihara, Midori Fujishiro. Hyponatremia Associated with Prophylactic Low-Dose Trimethoprim during Systemic Corticosteroid Therapy for AQP4-Positive Optic Neuritis in a Diabetic PatientAntibiotics 2020; 9(4): 201 doi: 10.3390/antibiotics9040201
43
Thierry Hannedouche, Patrick Rossignol, Patrice Darmon, Jean-Michel Halimi, Patrick Vuattoux, Albert Hagege, Ludivine Videloup, Francis Guinard. Early diagnosis of chronic kidney disease in patients with diabetes in France: multidisciplinary expert opinion, prevention value and practical recommendationsPostgraduate Medicine 2023; 135(7): 633 doi: 10.1080/00325481.2023.2256208
44
Sara Erraez, Manuel López-Mesa, Pablo Gómez-Fernández. Bloqueantes del receptor mineralcorticoide en la enfermedad renal crónicaNefrología 2021; 41(3): 258 doi: 10.1016/j.nefro.2020.10.001
45
Silvia Matino, Francesco Pesce, Michele Rossini, Giuseppina D’Ettorre, Alessandro Mascolo, Loreto Gesualdo. Endocrinology and Systemic DiseasesEndocrinology 2021; : 123 doi: 10.1007/978-3-319-68729-2_5
46
Satoru Kuriyama. Protection of the kidney with sodium–glucose cotransporter 2 inhibitors: potential mechanisms raised by the large-scaled randomized control trialsClinical and Experimental Nephrology 2019; 23(3): 304 doi: 10.1007/s10157-018-1673-0
47
Christiane I Ramos, Ailema González-Ortiz, Angeles Espinosa-Cuevas, Carla M Avesani, Juan Jesus Carrero, Lilian Cuppari. Does dietary potassium intake associate with hyperkalemia in patients with chronic kidney disease?Nephrology Dialysis Transplantation 2021; 36(11): 2049 doi: 10.1093/ndt/gfaa232
48
Ahmed Abdelaal Ahmed Mahmoud, Mark Campbell, Margarita Blajeva. Can ACE-I Be a Silent Killer While Normal Renal Functions Falsely Secure Us?Case Reports in Anesthesiology 2018; 2018: 1 doi: 10.1155/2018/1852016
49
K. V. Skobeleva, L. V. Tyrtova. The effect of the components of the renin-angiotensinaldosterone system on the development of diabetic nephropathy in type 1 diabetes (review)Nephrology (Saint-Petersburg) 2021; 25(2): 43 doi: 10.36485/1561-6274-2021-25-2-43-51
50
Masanori Adachi, Keiko Nagahara, Ayako Ochi, Junya Toyoda, Koji Muroya, Katsumi Mizuno. Acid–Base Imbalance in Pseudohypoaldosteronism Type 1 in Comparison With Type IV Renal Tubular AcidosisJournal of the Endocrine Society 2022; 6(12) doi: 10.1210/jendso/bvac147
51
Mark A. Curran. Critical Care Obstetrics2018; : 519 doi: 10.1002/9781119129400.ch34
52
Antoine-Guy Lopez, Céline Duparc, Julien Wils, Alexandre Naccache, Mireille Castanet, Hervé Lefebvre, Estelle Louiset. Steroidogenic cell microenvironment and adrenal function in physiological and pathophysiological conditionsMolecular and Cellular Endocrinology 2021; 535: 111377 doi: 10.1016/j.mce.2021.111377
53
Vandana S Mathur, Elizabeth Li, Donald E Wesson. Effects of veverimer on serum bicarbonate and physical function in diabetic patients with chronic kidney disease and metabolic acidosis: subgroup analysis from a randomized, controlled trialNephrology Dialysis Transplantation 2022; 37(7): 1302 doi: 10.1093/ndt/gfab209
54
Toshiyuki Yano, Satoshi Katano, Hidemichi Kouzu, Ryohei Nagaoka, Takuya Inoue, Yuhei Takamura, Tomoyuki Ishigo, Ayako Watanabe, Katsuhiko Ohori, Masayuki Koyama, Nobutaka Nagano, Takefumi Fujito, Ryo Nishikawa, Akiyoshi Hashimoto, Tetsuji Miura. Distinct determinants of muscle wasting in nonobese heart failure patients with and without type 2 diabetes mellitusJournal of Diabetes 2021; 13(1): 7 doi: 10.1111/1753-0407.13090
55
Gregory L. Hundemer, Manish M. Sood. Hyperkalemia with RAAS inhibition: Mechanism, clinical significance, and managementPharmacological Research 2021; 172: 105835 doi: 10.1016/j.phrs.2021.105835
56
Laurence Lepage, Katherine Desforges, Jean-Philippe Lafrance. New drugs to prevent and treat hyperkalemiaCurrent Opinion in Nephrology and Hypertension 2016; 25(6): 524 doi: 10.1097/MNH.0000000000000272
57
Yanru Wang, Yuxing Chen, Yanping Yu, Xin Pan, Guoxiang Fu. Association of urinary calcium excretion with chronic kidney disease in patients with type 2 diabetesInternational Urology and Nephrology 2024;  doi: 10.1007/s11255-024-03978-x
58
Gürkan Tarçın, Saffa Ahmadzada, Seha Saygılı, Ayşem Kaya, Ayşe Çiğdem Aktuğlu Zeybek, Oya Ercan. Evaluating renin and aldosterone levels in children with organic acidemia—therapeutic experience with fludrocortisoneEuropean Journal of Pediatrics 2023; 182(12): 5447 doi: 10.1007/s00431-023-05221-8
59
David S. Goldfarb, Jon-Emile S. Kenny. Nephrology Secrets2019; : 549 doi: 10.1016/B978-0-323-47871-7.00087-3